Bacteriophages as Solid Tumor Theragnostic Agents

• Published in: International journal of molecular sciences Vol. 23; no. 1; p. 402
• Main Authors: Veeranarayanan, Srivani, Azam, Aa Haeruman, Kiga, Kotaro, Watanabe, Shinya, Cui, Longzhu
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 30.12.2021; MDPI
• Subjects: Animals; bacteriophages; Bacteriophages - physiology; Biological products; Blood vessels; Brain cancer; Cancer; Cancer therapies; Cancer Vaccines - immunology; Cell cycle; Chemotherapy; Disease; Drug resistance; Fibroblasts; Fingerprints; Genetic engineering; Human body; Humans; Laboratory animals; Metabolism; Metastasis; Mutation; Neoplasms - diagnosis; Neoplasms - therapy; Permeability; Phage display; Phage Therapy; Phages; Physiology; Radiation; Review; Solid tumors; theragnostics; tumor; Tumor Microenvironment; Tumors; theragnostics; tumor; bacteriophages
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23010402

Cancer, especially the solid tumor sub-set, poses considerable challenges to modern medicine owing to the unique physiological characteristics and substantial variations in each tumor's microenvironmental niche fingerprints. Though there are many treatment methods available to treat solid tumors, still a considerable loss of life happens, due to the limitation of treatment options and the outcomes of ineffective treatments. Cancer cells evolve with chemo- or radiation-treatment strategies and later show adaptive behavior, leading to failed treatment. These challenges demand tailored and individually apt personalized treatment methods. Bacteriophages (or phages) and phage-based theragnostic vectors are gaining attention in the field of modern cancer medicine, beyond their bactericidal ability. With the invention of the latest techniques to fine-tune phages, such as in the field of genetic engineering, synthetic assembly methods, phage display, and chemical modifications, noteworthy progress in phage vector research for safe cancer application has been realized, including use in pre-clinical studies. Herein, we discuss the distinct fingerprints of solid tumor physiology and the potential for bacteriophage vectors to exploit specific tumor features for improvised tumor theragnostic applications.